129 related articles for article (PubMed ID: 17374963)
1. Frequency of mutated allele CYP2D6*4 in the Turkish population.
Koseler A; Ilcol YO; Ulus IH
Pharmacology; 2007; 79(4):203-6. PubMed ID: 17374963
[TBL] [Abstract][Full Text] [Related]
2. The frequencies of mutated alleles of CYP2D6 gene in a Turkish population.
Serin A; Canan H; Alper B; Gulmen M
Forensic Sci Int; 2012 Oct; 222(1-3):332-4. PubMed ID: 22910059
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 and CYP1A1 mutations in the Turkish population.
Aydin M; Hatirnaz O; Erensoy N; Ozbek U
Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of CYP2D6 in Chinese mainland.
Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M
Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923
[TBL] [Abstract][Full Text] [Related]
5. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
Buzková H; Pechandová K; Slanar O; Perlík F
Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of CYP2D6 in the Japanese population.
Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 CYP2D6.
Wolf CR; Smith G
IARC Sci Publ; 1999; (148):209-29. PubMed ID: 10493260
[TBL] [Abstract][Full Text] [Related]
8. Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls.
Erden G; Acar FS; Inal EE; Soydas AO; Ozoran K; Bodur H; Yildirimkaya MM
Rheumatol Int; 2009 Oct; 29(12):1431-4. PubMed ID: 19242697
[TBL] [Abstract][Full Text] [Related]
9. Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.
Bathum L; Johansson I; Ingelman-Sundberg M; Hørder M; Brøsen K
Pharmacogenetics; 1998 Apr; 8(2):119-23. PubMed ID: 10022749
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of CYP2D6 poor metabolizers among schizophrenia patients.
Llerena A; Dorado P; Peñas-Lledó EM; Cáceres MC; De la Rubia A
Pharmacogenomics J; 2007 Dec; 7(6):408-10. PubMed ID: 17325735
[TBL] [Abstract][Full Text] [Related]
12. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.
Kato D; Kawanishi C; Kishida I; Furuno T; Matsumura T; Hasegawa H; Suzuki K; Hirayasu Y
Psychiatry Clin Neurosci; 2005 Aug; 59(4):504-7. PubMed ID: 16048458
[TBL] [Abstract][Full Text] [Related]
15. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J; Weihe P; Brosen K
Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
[TBL] [Abstract][Full Text] [Related]
16. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
[TBL] [Abstract][Full Text] [Related]
17. Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction.
Endrizzi K; Fischer J; Klein K; Schwab M; Nüssler A; Neuhaus P; Eichelbaum M; Zanger UM
Anal Biochem; 2002 Jan; 300(2):121-31. PubMed ID: 11779102
[TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacogenetics in the treatment of schizophrenia].
Saito M; Yasui-Furukori N; Kaneko S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
[TBL] [Abstract][Full Text] [Related]
19. A long PCR assay to distinguish CYP2D6*5 and a novel CYP2D6 mutant allele associated with an 11-kb EcoRI haplotype.
Ishiguro A; Kubota T; Sasaki H; Iga T
Clin Chim Acta; 2004 Sep; 347(1-2):217-21. PubMed ID: 15313161
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study.
Teh LK; Zilfalil BA; Marina I; Rosemi BS; Ismail R
J Clin Pharm Ther; 2004 Dec; 29(6):559-64. PubMed ID: 15584944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
